doi: 10.1186/s13578-022-00897-1, 133 XiJ.ZhangZ.WangZ.WuQ.HeY.XuY.et al
Given the current supply landscape for GLP-1 therapies, compounded versions of drugs such as tirzepatide and semaglutide are intended to be prepared on a patient-specific basis pursuant to a valid prescription
In contrast, long-acting agents appear to have a larger effect on lowering fasting glucose due to their effect to increase insulin release and inhibit glucagon release (Meier 2012)
Pharmacokinetic Parameters Clinical Uses Type 2 diabetes mellitus Obesity management Cardiovascular risk reduction in patients with diabetes Nonalcoholic fatty liver disease (off-label, investigational) Adverse Effects Nausea and vomiting Diarrhea Pancreatitis (rare) Thyroid C-cell tumors (rodent studies) Injection site reactions (if injectable) Comparative Analysis MCQs GLP-1 receptor agonists primarily act on: a) Alpha cells b) Beta cells c) Delta cells d) Hepatocytes Answer: b) Beta cells These drugs increase insulin secretion in a: a) Continuous manner b) Glucose-independent way c) Glucose-dependent way d) Inhibited state Answer: c) Glucose-dependent way Which of the following is a known adverse effect of GLP-1 agonists
Everyone using an Infrared Saunaor any sauna for that mattershould be aware of general standard precautions and take care not to become dehydrated or overheated, which can lead to dizziness
Adjustments are made based on how the patient responds
